Literature DB >> 10461159

Praziquantel--its use, cost and possible development of resistance.

J Kusel, P Hagan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10461159     DOI: 10.1016/s0169-4758(99)01510-0

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


× No keyword cloud information.
  6 in total

1.  Hepatic schistosomiasis.

Authors:  Karin L Andersson; Raymond T Chung
Journal:  Curr Treat Options Gastroenterol       Date:  2007-12

2.  Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya.

Authors:  C H King; E M Muchiri; J H Ouma
Journal:  Emerg Infect Dis       Date:  2000 Nov-Dec       Impact factor: 6.883

Review 3.  Novel therapeutic and prevention approaches for schistosomiasis: review.

Authors:  Rashika A F El Ridi; Hatem A-M Tallima
Journal:  J Adv Res       Date:  2012-06-23       Impact factor: 10.479

4.  Efficacy of China-made praziquantel for treatment of Schistosomiasis haematobium in Africa: A randomized controlled trial.

Authors:  Xin-Yao Wang; Jian He; Saleh Juma; Fatma Kabole; Jia-Gang Guo; Jian-Rong Dai; Wei Li; Kun Yang
Journal:  PLoS Negl Trop Dis       Date:  2019-04-10

5.  Therapeutic Effect and Immune Changes after Treatment of Hymenolepis nana-Infected BALB/c Mice with Compounds Isolated from Leucaena leucocephala.

Authors:  Yi-Hsuan Ma; Chung-Yi Chen; Li-Yu Chung; Chuan-Min Yen; Yung-Shun Juan; Rong-Jyh Lin
Journal:  Vet Sci       Date:  2022-07-18

6.  Natural products as a source for treating neglected parasitic diseases.

Authors:  Dieudonné Ndjonka; Ludmila Nakamura Rapado; Ariel M Silber; Eva Liebau; Carsten Wrenger
Journal:  Int J Mol Sci       Date:  2013-02-06       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.